Stephanie Teal is a Gynecologic physician. OpenAlex indexes 176 publications with 4,011 citations (h-index 34); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Obstetrics & Gynecology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
Sponsor: University of Colorado, Denver
- Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
Sponsor: University of Colorado, Denver
- Intra Uterine Device Insertion in Nulliparous Women
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BayerProgram year20251 paymentResearch$50,293openpaymentsdata.cms.gov ↗
- MylanProgram year20257 paymentsResearch$10,174openpaymentsdata.cms.gov ↗
- MylanProgram year202420 paymentsResearch$33,591openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
2 NIH research awards on record, funded 2014–2025 per NIH RePORTER. The latest:
- CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - CU DENVER
University of Colorado
FY2025$3,38175N94020D00019 - CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION - CU DENVER
University of Colorado Denver
FY2024$111,644275201300003I - CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - CU DENVER
University of Colorado
FY2024$16,81575N94020D00019
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users
Obstetrics and Gynecology
2022 - Maternal morbidity after preterm premature rupture of membranes at <24 weeks’ gestation
American Journal of Obstetrics and Gynecology
2021 - Reproductive services for women at high risk for maternal mortality: a report of the workshop of the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the Fellowship in Family Planning, and the Society of Family Planning
American Journal of Obstetrics and Gynecology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Bradley Monk, MD
Florida Cancer Specialists & Research Institute
Angeles Secord, MD
Duke University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”